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Abstract
Background: Avoidance of antigenic stimuli was found to significantly reverse airway obstruction of horses with
severe equine asthma (sEA). To date, no published study investigated the influence of steaming hay on lower
airway condition of sEA-affected horses. The objectives were to determine the clinical, cytological and cytokine
respiratory responses of both sEA and control (CTL) horses experimentally exposed to steamed or dry hay.
Results: A cohort of 6 sEA horses and 6 CTL horses was involved in this field study. On day 0, both groups were
fed with steamed hay for 5 consecutive days, followed by a wash-out period of 26 days prior to be fed with dry
hay for 5 consecutive days. Investigations performed 2 days prior to and 5 days after each challenge included
clinical score, tracheal mucus accumulation, and bronchoalveolar lavage fluid (BALF) cytology and cytokine mRNA
expression. Feeding steamed hay significantly decreased its mould content (P < 0.001). Mucus score significantly
increased when feeding dry hay (P = 0.01). No significant influence of challenge type was found on clinical score.
Percentages of neutrophils (P < 0.001) as well as mRNA expression of IL-1β (P = 0.024), IL-6R (P = 0.021), IL-18 (P = 0.
009) and IL-23 (P = 0.036) in BALF of sEA affected horses were significantly increased after both (steamed and dry
hay) challenges. Relative mRNA expression of IL-1β, IL-6R and IL-23 in BALF were also significantly correlated to
neutrophil percentages and both clinical and tracheal mucus score.
Conclusions: Steaming significantly decreased mould content but inconsistently influenced the respiratory
response of sEA affected horses when fed hay. Based on BALF cytology and cytokine profiles, its relevance might
be controversial as a non-medicinal therapy for sEA-affected horses.
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Background
Severe equine asthma (sEA; previously known as recur-
rent airway obstruction) is a chronic disease of adult
horses characterised by frequent coughing and increased
respiratory effort at rest, as well as marked lower airway
inflammation and reversible airway obstruction [1]. While
neutrophils involvement in the pathophysiology of this
disease is well defined, controversies still persist in terms
of T-helper (Th)-1 and/or Th-2 polarisation, as deter-
mined by cytokines mRNA expression in BALF-derived
cells [2, 3]. Involvement of Th-17 pathway [4, 5] and regu-
latory T cells (Treg; [6]) have also been suggested. Expos-
ure to airborne environmental antigens is central in both
initiation and maintenance of the disease, especially
through stabling and exposure to hay and straw [7]. Feed-
ing mouldy hay indeed represents a long-established
model for sEA exacerbation in susceptible horses [2], and
also allows differentiation from mild/moderate equine
asthma (mEA; previously known as inflammatory airway
disease) [3]. Inhalation challenges with aqueous mould
extracts were previously found to induce neutrophilic
inflammation in sEA affected horses but not in controls
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horses to hay dust suspensions highlighted the synergistic
effect of endotoxins and other dust components [9].
Environmental change, especially pasture turnout, with
or without anti-inflammatory medication was found to
significantly reverse airway obstruction of sEA affected
horses [10]. On the other hand, corticosteroid therapy
while maintaining the horse in a dusty environment leads
to improved clinical signs and lung function but persistent
airway inflammation [11, 12]. Feeding haylage and bed-
ding wood shavings have been associated with significantly
lower levels of both respirable dust (< 5 μm diameter) and
endotoxins, within the horse’s breathing zone, when com-
pared to hay/straw environment [13, 14]. Alternatively,
soaking and high-temperature steaming of hay for 16 h
and 50 min respectively, significantly reduced respirable
particles exposure; however endotoxin levels were not in-
vestigated [15, 16]. Steaming was also found to be effective
at reducing mould content in hay, unlike soaking hay for
9 h [17]. Steaming hay indeed aims to reach and uniformly
diffuse a temperature of 100 °C within the hay bale. To
date, there is no published study that has investigated the
potential influence of steaming hay on lower airway in-
flammation of sEA-affected horses.
The aim of the study was to determine clinical, cyto-
logical and cytokine respiratory responses of both sEA
and control (CTL) horses experimentally exposed to
steamed or dry hay. Our hypothesis was that feeding sEA
affected horses with dry hay will result in higher respirable
dust exposure, airway inflammation and clinical signs, as
compared to feeding high-temperature steamed hay.
Steaming hay indeed significantly decreased mould con-
tent but inconsistently influenced the respiratory response
of sEA-affected horses. Both cytological and cytokine pro-
files actually revealed a significant airway inflammation
when feeding hay (steamed or not).
Results
One sEA horse exhibited fever during the wash-out
period and was subsequently excluded from the study.
In the end, 5 sEA horses and 6 CTL horses completed
both challenges (Additional file 1).
Hay and air sampling
Both bacterial and mould content were significantly
lower (P < 0.001) in steamed hay (195 280 ± 465 270 and
1 507 ± 1 864 CFU/g, respectively), when compared to
dry hay (4 042 000 ± 6 748 619 and 118 150 ± 187
624 CFU/g, respectively; Additional file 2). Aspergillus
family (principally A. glaucus and A. nidulens) was iden-
tified in 9/10 samples of dry hay and 10/10 samples of
steamed hay; Aspergillus fumigatus has been identified
in one sample of dry hay only. Similarly, Penicillium spp.
was identified in 3/10 samples of dry hay and 1/10 sam-
ples of steamed hay. Concentrations of respirable dust
collected within the breathing zones (CTL and sEA
horse) were 0.0015 and 0.0034 mg/m3, respectively, dur-
ing challenge #1 (steamed hay) vs. 0.0024 and
0.0057 mg/m3 during challenge #2 (dry hay). Similarly,
the inhalable fractions collected were 0.0045 and
0.0082 mg/m3, respectively, during challenge #1 vs. 0.31
and 0.26 mg/m3 during challenge #2. Endotoxin activ-
ities from respirable fraction were 0.08 and 0.98 EU/mL,
respectively, during challenge #1, vs. 2.19 and 3.88 EU/
mL during challenge #2. Levels of β-D-glucan were 340
and 1067 pg/mL, respectively, during challenge #1, vs.
895 and 2367 pg/mL during challenge #2.
Clinical score and tracheal mucus
Overall, the mean clinical scores were not significantly
different between sEA and CTL horses (‘disease status’;
P = 0.071) and no significant influence on clinical scores
was found for either ‘challenge’ or ‘time’ (Fig. 1), control-
ling for age. A significant interaction (P = 0.049) was
found for clinical score between ‘challenge’ (steamed vs.
dry hay) and ‘time’ (d + 5 vs. d-2); the post-hoc tests
were however not significant for any further comparison.
Mean mucus score was significantly higher (P = 0.005)
for sEA horses when compared to CTL horses and over-
all significantly higher (P = 0.024) at d + 5 when
compared to d-2 (Fig. 1). A significant interaction (P =
0.022) was also found for tracheal mucus between ‘chal-
lenge’ and ‘time’; the score being significantly higher for
dry hay at d + 5 when compared to d-2 (P = 0.01), but
not significantly different between d + 5 and d-2 for
steamed hay (P = 0.98).
BALF cytology
After controlling for age, no significant influence on the
proportions of BALF volume recovered was found for
either ‘challenge’, ‘time’ or ‘disease status’, nor any inter-
action between categories. Total cell counts were overall
significantly higher (P = 0.037) for sEA compared to
CTL horses (Additional file 3). The mean percentage of
BALF neutrophils was significantly higher (P = 0.011) for
sEA horses when compared to CTL horses and was
overall significantly higher (P < 0.001) at d + 5 when
compared to d-2 (Fig. 2), while no significant interaction
was found between ‘challenge’ and ‘time’ (P = 0.197). The
mean percentage of BALF lymphocytes was significantly
lower (P = 0.001) at d + 5 when compared to d-2. A
significant interaction (P = 0.009) was found between
‘disease status’ and ‘time’ for the percentage of BALF
macrophages; the post-hoc tests being however not
significant. The mean percentage of BALF metachromatic
cells were significantly lower (P = 0.001) for sEA horses
when compared to CTL horses (Additional file 3). No
overall influence of the ‘challenge’ type (steamed vs. dry
hay), or any interaction between ‘challenge’ and either
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‘time’ or ‘disease status’ was found for any of the investi-
gated cytological parameters.
BALF cytokines
After controlling for age, mean mRNA expression was
significantly lower for IL-4 (P = 0.022) and significantly
higher for IL-17 (P < 0.001) and TNF-α (P = 0.006) in
BALF of sEA affected horses, when compared to CTL
horses (Fig. 3). Overall mRNA expression of IL-10 was
significantly higher (P < 0.001) at d + 5 when compared
to d-2, irrespective of the horse disease status (Fig. 3).
Significant interactions were found between ‘disease sta-
tus’ and ‘time’ (higher at d + 5 than d-2 for sEA horses
only) for relative mRNA expression of IL-1β (P = 0.024),
IL-6R (P = 0.021), IL-18 (P = 0.009) and IL-23 (P = 0.036)
in BALF (Fig. 4). No significant variation was found
throughout challenges for relative mRNA expression of
IL-2, IL-5, IL-6, IL-8, IL-13, IFN-γ and TGF-β (Additional
file 4). No overall influence of the ‘challenge’ type
(steamed vs. dry hay), or any interaction between ‘chal-
lenge’ and either ‘time’ or ‘disease status’ was found for
any cytokine relative expression in BALF.
Correlations
Relative mRNA expression of IL-1β, IL-6R, IL-8, IL-10
and IL-23 were significantly associated with BALF neu-
trophil percentages of sEA affected horses (Fig. 5), and
mRNA expression of IL-1β, IL-6R, IL-8, IL-13, IL-23
and TGF-β in BALF were also significantly correlated
with tracheal mucus score (Additional file 5). Relative
mRNA expression of IL-6R was negatively correlated
with the percentage of macrophages in BALF of sEA af-
fected horses, and IL-4 was significantly correlated with
metachromatic cell percentages (Additional file 5).
Discussion
This is, to our knowledge, the first study in which the
inflammatory and immune airway responses of both
sEA and CTL horses have been investigated through a
controlled exposition challenge with steamed and dry
hay. Horses with sEA had been on pasture for at least
6 weeks prior to the challenge initiation. Unsurprisingly
and due to the persistent nature of this syndrome, some
level of clinical and/or cytological abnormalities at the
time of enrolment was observed for 2 out of the 5
sEA-affected horses. Interestingly, the initial clinical
scores were indeed 12/21 for both horses, and decreased
to 6/21 at the end of the first exposure period (to
steamed hay). Despite a significant interaction between
‘challenge’ (steamed vs. dry hay) and ‘time’ (d + 5 vs.
Fig. 1 a Clinical score and b tracheal mucus score, before and after the initiation of each challenge. sEA, severe equine asthma; CTL, control; d-2,
2 days before challenge; d + 5, 5 days after challenge. *, ** significant difference between groups (P < 0.05 and < 0.01), based on ANOVA
investigation. Significant overall interactions (P < 0.05) were also found between ‘challenge’ (steamed, dry) and ‘time’ (d-2, d + 5); the p-value
correspond to the subsequent Tukey-Kramer’s post-hoc test
Fig. 2 a) Mean neutrophil percentages in bronchoalveolar lavage
fluid (BALF), before and after the initiation of each challenge; a’)
focus (same data) on the control horses. sEA, severe equine asthma;
CTL, control; d-2, 2 days before challenge; d + 5, 5 days after
challenge. *, *** significant difference between groups or timepoints
(P < 0.05 and 0.001, respectively), based on ANOVA investigation
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d-2), the individual variability of clinical scores may have
confounded the results. However, 4 out of the 5 sEA
horses showed significantly (P = 0.01) elevated tracheal
mucus score (≥ 3) after being fed dry hay, while the
score remained < 3 for a majority of them (3 out of 5)
after being fed steamed hay.
Percentages of neutrophils in BALF were overall
higher at d + 5 when compared to d-2, irrespective of
‘challenge’ (steamed and dry hay) and ‘disease status’
(sEA and CTL). Induction of a significant neutrophilic
airway inflammation has been previously reported in
CTL horses through environmental challenges [18, 19].
In the present study, all BALF neutrophil percentages
measured from CTL horses systematically remained
< 10%, while the same “good quality” (non-mouldy)
hay was used in both challenges. Steaming hay signifi-
cantly decreased mould content by a hundred fold, as
previously described [17]. The mould content in hay
was investigated in the present study by mycological
culture only; the presence of spores, antigenic frag-
ments or mycotoxins has not been evaluated. Targeted
and non-targeted methodologies, such as qPCR and
Maldi-Tof mass spectrometry, respectively, would con-
siderably increase both the sensitivity and broadness of
aeroallergen detection.
Based on the inflammatory responses measured after
both challenges, it might be hypothesised that other
non-evaluated stimuli might still be present within the
hay even after steaming (e.g. mould and bacterial wall
fragments). Horses were kept in paddocks during expos-
ure periods, in order to avoid the influence of environ-
mental confinement [20] and associated management of
stables ventilation. Alternatively, steaming hay may not
have been sufficient to prevent the synergistic inflamma-
tory activity of various hay dust components, especially
including endotoxins, which has previously been demon-
strated experimentally [9]. When considering air
sampling within the breathing zone during the present
study, the inhalable fraction was 100 times lower when
feeding steamed hay compared to dry hay. The influence
of steaming hay on the respirable particles was however
more limited in the current study, while this fraction
was found to be significantly associated with lower
airway inflammation of horses [21]. Respirable dust,
endotoxin and β-D-glucan levels may also have been
affected by individual horse’s behaviour when eating hay,
as previously demonstrated for particulate concentra-
tions [22]. The mean values measured for endotoxin
activities within the breathing zones were 5.7 times
lower with steamed hay, when compared to dry hay,
Fig. 3 Relative mRNA expression of cytokines in bronchoalveolar lavage fluid (BALF), before and after the initiation of each challenge: a
tumour necrosis factor (TNF)-α; b interleukin (IL)-17; c IL-4; d IL-10. sEA, severe equine asthma; CTL, control; d-2, 2 days before challenge;
d + 5, 5 days after challenge. *, **, *** significant difference between groups or timepoints (P < 0.05, 0.01 and 0.001, respectively), based
on ANOVA investigation
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while a large variability was observed among horses. Inter-
estingly, values for endotoxin activities within the breath-
ing zone when feeding steamed hay were also comparable
with previously published data for haylage/wood shavings
combination [14].
No significant influence of the ‘challenge’ type (steamed
vs. dry hay) was found for any cytokine mRNA expression
in BALF. Significant interactions were found between ‘dis-
ease status’ (sEA vs. CTL) and ‘time’ (d + 5 vs. d-2) for
mRNA expression of IL-1β and IL-18; relative mRNA ex-
pression of TNF-α was also significantly higher in BALF
from sEA affected horses, when compared with CTL
horses. Such observations are coherent with the measurable
inflammatory response of sEA affected horses to both
(steamed and dry) hay challenges. Interestingly, mRNA ex-
pression of IL-6R in BALF was also increased
post-challenges for sEA affected horses only. To date, the
relative expression of this receptor has not been investi-
gated in BALF of horses. Interestingly, a genome-wide asso-
ciation study identified a significant association between a
single nucleotide polymorphism in the IL-6R gene and the
risk of asthma in humans [23]. Further investigations are
warranted to characterize the IL- 6 signaling pathway
involvement in equine asthma, especially in terms of
subsequent T-helper (Th) polarisation as recently demon-
strated in humans [24].
The previously suggested involvement of Th17 path-
way in the airways of horses with severe asthma [4, 5], is
supported by the present study. Overall IL-17 mRNA ex-
pression was indeed significantly higher in BALF of sEA
affected when compared with CTL horses. The IL-23
mRNA expression in BALF was also increased
post-challenges for sEA affected horses only, and was
furthermore significantly correlated with both tracheal
mucus score and BALF neutrophil percentages. Surpris-
ingly, IL-8 mRNA expression was neither significantly
different among groups (P = 0.11; controlling for age of
the horses) nor significantly influenced by the challenge
types. However, a significant correlation (R = 0.688) was
found with neutrophil percentages in BALF. While over-
expression has been associated with sEA chronicity [4, 5],
it is likely that IL-8 contributes to neutrophil chemotaxis
in the earlier stages of equine asthma [2]. The short dur-
ation of each challenge period in the current study might
partly explain the limited amplitude of IL-8 mRNA
expression in BALF.
The lower mRNA expression of IL-4 in BALF of sEA
versus CTL horses was unexpected, mainly based on the
Fig. 4 Relative mRNA expression of cytokines in bronchoalveolar lavage fluid (BALF), before and after the initiation of each challenge: a
interleukin (IL)-1β; b IL-18; c IL-6R; d IL-23. sEA, severe equine asthma; CTL, control; d-2, 2 days before challenge; d + 5, 5 days after challenge.
Significant overall interactions (P < 0.05) were found between between ‘disease status’ (sEA, CTL) and ‘time’ (d-2, d + 5); the p-values
correspond to the subsequent Tukey-Kramer’s post-hoc tests
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previously demonstrated Th2 polarisation for this syn-
drome [25]. Interestingly, mRNA expression of IL-4 in
BALF of both sEA and CTL horses was also not signifi-
cantly influenced by either challenge. The sEA group
exhibited significantly lower percentages of metachrom-
atic cells in BALF, when compared to CTL horses; and
IL-4 mRNA expression was significantly correlated with
both eosinophil and metachromatic cell percentages.
When considering a possible Treg involvement in sEA,
mRNA expression of TGF-β was interestingly not signifi-
cantly modified throughout the study. On the other hand,
IL-10 was the only cytokine which mRNA expression in
BALF was significantly higher post-challenges and
correlated to BALF neutrophil proportions, with however
no significant difference between sEA and CTL horses.
Surprisingly, mRNA expression of IL-10 in BALF from
sEA affected horses was previously found not to be signifi-
cantly influenced by various environmental challenges
[26]. Alternatively, percentages of different Treg subpopu-
lations, as characterised by flow cytometry, were found to
be significantly higher in BALF of sEA horses during crisis
exacerbation when compared to remission [6].
Study limitations
All 12 horses involved in this field trial were
client-owned, with differences in terms of geographic
Fig. 5 Correlations (95% confidence interval) between relative mRNA expression of cytokines and neutrophil proportions in bronchoalveolar
lavage fluid (BALF) of sEA affected horses, before and after the initiation of each challenge: a interleukin (IL)-1β; b IL-8; c IL-6R; d IL-10; e IL-23.
Straight line, linear regression; dotted lines, 95% confidence
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origins prior to enrolment in the study. The limited
number of horses enrolled in this study was consistent
with similar works previously published [4, 8]. Based on
the current results, the retrospective statistical power
analyses highlights the variability of sample size required
in relation to the multiple outcomes investigated. Values
of power indeed ranged from 30% for clinical score to
82 and 98% for respectively mucus score and BALF neu-
trophil percentages. Unlike mucus and cytology (for
which estimated sample size = 4–6), a minimum of 20
horses would have been required for clinical signs to
reach a 80% power with a α-level of 0.05. The average
age was significantly different between groups; the CTL
horses being significantly younger than the sEA affected
horses. This confounding factor was then taken into ac-
count in all further statistical analyses. In terms of de-
sign, both challenges (steamed and dry hay) were not
performed as a cross-over study, since horses were ini-
tially fed with steamed hay (challenge #1) and subse-
quently fed dry hay (challenge #2). For ethical reasons,
the design (i.e. steamed then dry hay) aimed at limiting
the risk of horse exclusion (due to crisis exacerbation
and subsequent treatment) at the end of the first expos-
ure period, which would have precluded the horse to be
involved in the second period. No significant difference
was found for each group at d-2 (i.e. initiation of each
exposure period) for all investigated parameters; suggest-
ing that horses returned to “baseline level” prior to chal-
lenge #2. Also, clinical and tracheal mucus scoring were
performed by clinicians not blinded to either challenge
type (steamed vs. dry) or horse disease status (sEA vs.
CTL), unlike all subsequent laboratory analyses, and
lung function tests were not available for this study. Fi-
nally, the immune responses in BALF were investigated
for the various cytokines through relative mRNA expres-
sions only. Measuring BALF cytokine concentrations
using commercially available ELISA kits however lacks
sensitivity, since many BALF samples previously showed
undetectable cytokine concentrations [27, 28].
Conclusions
Steaming hay significantly decreased mould content and
induced less tracheal mucus in horses. However, both
types of hay (steamed or not) induced BALF neutrophi-
lia, and none induced respiratory clinical signs. The rele-
vance of steaming hay however warrants further
investigations both in the context of prevention/therapy
for mEA horses at training and for long-term preclusion
of lately developing sEA.
Methods
Horses
A cohort of 12 privately owned leisure horses were used
in the study, and was subdivided into 2 separate groups.
The control (CTL) group included 6 young horses (4
mares and 2 geldings, aged 2–5 years). These horses had
no history of coughing or nasal discharge, exhibited no
tracheal mucus upon endoscopy, and had less than 10%
neutrophils in bronchoalveolar lavage fluid (BALF) from
each lung when investigated 10 days prior to the trial.
The other group included 6 adult horses (5 mares and 1
gelding, aged 9–17 years) that had all previously been
diagnosed by the same clinician as suffering from sEA,
based on clinical investigations, BALF cytology and re-
versible airway obstruction after medical/environmental
change. Only horses kept in pasture and without any
medical treatment or access to hay for at least 1 month
prior to the trial were enrolled in the study. Recruitment
for the study was made on a volunteer basis from private
training centres (CTL horses) and from the caseload
previously referred to the hospital (sEA horses; Oniris,
Nantes). All owners signed an informed consent, and all
procedures were performed by veterinarians and com-
plied with relevant guidelines (Directive 2010/63/EU).
The study was also approved by the Institutional Ethic
Committee for Clinical Research (CERVO-2017-8-V).
Study design
This study was conducted during spring 2017. At the
initiation of the trial, all horses were gathered and kept
in a 4 ha pasture without access to hay for a duration of
2 weeks (Fig. 6). Since stabling was previously found to
be associated with increased airway inflammation [29],
horses were kept in 1 000 m2 paddocks by subgroups of
three individuals during both exposure periods. On day
0 of the trial, both groups (sEA and CTL) were fed on
the ground with about 5 kg per horse of steamed hay
(challenge #1), twice daily for 5 consecutive days (i.e. ex-
posure period #1); followed by a wash-out period of
26 days in the 4 ha pasture without access to hay, prior
to a second challenge with similar distribution of dry
hay (challenge #2) for 5 consecutive days, (exposure
period #2). Horses had access to water ad libitum and
were also fed flaked cereals and dry pellets (Twenty
Horse1) twice daily. Good quality (non-mouldy) grass
hay was harvested as square bales (12–15 kg). For the
challenge #1, the hay was steamed using a commercial
device (HG-6002), according to manufacturer’s recom-
mendations, and immediately distributed to horses.
Briefly, the hay bale was placed onto the steamer and
pushed down firmly until the manifold spikes pierce the
hay to their full length; the steam generator (containing
water) was then activated and steam diffused in hay
through the spikes. At the end of exposure period #2,
asthmatic horses received dexamethasone (0.1 mg/kg IV
for 2 days, then progressively decreasing doses over
1 week) and all horses (sEA and CTL) were returned
to their owners. Two days before (d-2) and 5 days
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after (d + 5) the initiation of each challenge, all horses
underwent a full clinical evaluation, as well as a tra-
cheal endoscopy and BALF sampling. The 2010 CON-
SORT guidelines for reporting clinical trial were used
for this report (Additional files 1 and 6) [30, 31].
Hay characterisation
Hay samples (random sampling by hand for a total of
1 kg) were collected from 10 different square bales be-
fore and after the steaming procedure, and stored in
dedicated bags1. All square bales originated from the
same batch of hay (one single pasture), and all analyses
were performed immediately after sampling. For bacteri-
ology, 20 g of crushed hay were mixed with 180 ml of
0.1% peptone water and diluted 1/10 up to 10− 6. One ml
of each dilution was plated onto a Plate Count Agar
(PCA) and incubated at 37 °C. One ml of each dilution
was also cultured in oxytetracycline-glucose-yeast Ex-
tract Agar (OGA) and incubated at 25 °C for fungal
growth. Bacterial and fungal growths were expressed as
colony forming units (CFUs) after 5 days of incubation.
The fungal colonies were then isolated on Sabouraud
agar in order to be identified.
Air quality
Air sampling within the breathing zone was per-
formed continuously for 2-3 h during hay feeding, on
d + 1 (one CTL horse) and d + 4 (one sEA horse) of
each exposure period. Respirable and inhalable partic-
ulates were collected according to previously pub-
lished procedures [21].
Particulates
Horses were equipped with two samplers. The respirable
fraction was collected with a flow rate of 2.5 L/min (Air-
Check XR50003) onto 37 mm type AE glass fibre filters
using aluminium cyclone. The inhalable fraction was
collected with a flow rate of 2.0 L/min (AirCheck 30003)
onto 25 mm PVC filters using Institute of Occupational
Medicine (IOM) personal sampler. Sampling pumps
were calibrated (Defender Bios calibrator3) before and
after sampling. Measurements of respirable and inhal-
able dust were assessed by gravimetric method, in tripli-
cate measurements. The weight of particulates was
divided by volume of air sampled to obtain airborne
concentrations. Filters were placed in a desiccator for
24 h prior to any weight measurement. Negative con-
trols were similarly prepared and only transported to
and from the site of trial.
Endotoxins
Endotoxins were measured from the 37 mm type AE
glass fibre filters, which were kept frozen (− 20 °C) after
particulates measurements. Filters were eluted in 10 mL
of 0.05% Tween 204 within pyrogen-free water. Samples
were then shaken during 1 h (MS-NRK-305). After elu-
tion, the suspension was centrifuged (1000 g; 15 min).
The supernatant was then kept frozen (− 20 °C) until be-
ing analysed. The eluates provided from sample filters
were diluted at 1/10 in pyrogen-free water. Endotoxin
activities were assayed using Endosafe – PTS2005F,6 ac-
cording to manufacturer’s recommendations.
β-D-glucan
Following endotoxin elution, heat extraction was per-
formed in order to measure (1–3)-β-D-glucan content.
Samples were then respectively diluted 10-fold for blank
filters and 100-fold for sample filters in pyrogen-free
water. Measures were carried out in duplicates, using a
Glucatell test,7 according to manufacturer’s recommen-
dations. The range of quantification was 5–40 pg/mL.
Fig. 6 Overview of the study: a experimental design, b climatic
conditions, and c geographical repartition
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Clinical score, tracheal mucus and bronchoalveolar lavage
fluid cytology
On d-2 and d + 5 for each exposure period, a clinical
score, based on a 0–21 scale (Additional file 7) [32], was
assigned to each horse. Detomidine hydrochloride
(0.01 mg/kg IV) and butorphanol tartrate (0.01 mg/kg
IV) was given prior to endoscopy. Airway endoscopy
and BAL collection were performed using a flexible
3.2 m long, 12.8 mm tip diameter videoendoscope.8 The
amount of tracheal mucus was scored (grade 0–5) ac-
cording to the previously published scale [33]. Left and
right lungs were then sampled according to previously
published procedures [34], with minor modifications.
Briefly, a total of 500 mL of warmed isotonic saline so-
lution (2 boluses of 250 mL each) was instilled and as-
pirated for each lung. Samples were conditioned (+ 4 °C
in EDTA tubes) and processed (cytocentrifugation,
May-Grünwald-Giemsa staining) as described previ-
ously [35]. Differential cell counts were performed on
300 leukocytes. Unlike clinical and mucus scores, cyto-
logical investigations of BALF from both lungs were
conducted by investigators blinded to challenge type
and horse status.
RNA isolation and reverse transcription
Each BALF sample obtained from the right lung was con-
ditioned in order to determine cytokine relative expres-
sions. Expression of 15 cytokines (representative of the
different pathways previously associated with sEA) and
one receptor (described in human allergic asthma) have
been targeted in this study: interferon (IFN)-γ, interleukin
(IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-6R, IL-8, IL-10, IL-12,
IL-13, IL-17, IL-18, IL-23, transforming growth factor
(TGF)-β and tumour necrosis factor (TNF)-α.
Twenty milliliters of BALF was centrifuged and the cell
pellets resuspended in RNA protect Cell Reagent.9 Total
RNA was extracted from cell pellets using the RNeasy
Plus Mini Kit9. Concentration and purity of total extracted
RNA was assessed using a NanoDrop 2000c Spectropho-
tometer10; and RNA integrity was evaluated using a 2100
Bioanalyzer11 and the RNA 6000 Nano kit11. Mean value
(± standard deviation) of RNA integrity number (RIN) for
all samples was 9.7 ± 0.2. After extraction, 200 ng was ret-
rotranscribed and cDNA generated using a Superscript
Vilo cDNA synthesis kit,12 according to the manufac-
turer’s recommendations. All cDNA samples were stored
at − 20 °C until further use. Apart from the cytokines of
interest, three reference genes, namely β-actin (ACTB),
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and β-glucuronidase (β-GUS), were also assessed. For
each reaction, cDNA was amplified in a 25 μl standard re-
action (Taqman Universal PCR Master Mix10). Thermal
cycling profile used was: 10 min at 95 °C, followed by
50 cycles of 15 s at 95 °C and 1 min at 60 °C. The relative
amount of mRNA was calculated using the relative stand-
ard curve method (Genex 6.113), and results were
expressed as mean fold difference (target / reference
genes). Using Normfinder, GAPDH and β-GUS were both
selected for normalization (Additional file 8). Molecular
investigations were also conducted blinded, in terms of
horse ‘disease status’ and ‘challenge’ type.
Statistical analyses
Continuous data distributions which were not normally
distributed, as assessed by Shapiro-Wilk W test, were
log-10 transformed. For hay-related parameters, paired t
tests (steamed vs. dry) were performed for the bacterial/
mould content. For all horse-related parameters, effects
of challenge (steamed vs. dry), time (d + 5 vs. d-2) and
disease status (sEA vs. CTL) were investigated by 3-way
analysis of variance (ANOVA, General Linear Model)
and Tukey-Kramer’s post-hoc tests, with age as covari-
ate. Correlations among sEA affected horses were deter-
mined by Spearman’s correlation coefficient. Absolute
values of R < 0.5 were arbitrarily not reported. The dif-
ferent analyses were conducted using Prism 714 and
NCSS12,15 and values of P < 0.05 were considered
significant.
Endnotes
1Tromelin & Cie, Ploeren, France
2Haygain, Lambourn, Berkshire, UK
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10Thermoscientific, Villebon-sur-Yvette, France
11Agilent Technologies, Les Ulis, France
12Life Technologies, Saint-Aubin, France
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Additional file 1: CONSORT flow diagram for the clinical trial involving
6 control (CTL) horses and 6 horses with severe equine asthma (sEA).
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Additional file 2: Microbiological content in hay (n = 10), before and
after steaming: a) bacterial content; b) mould content. *** significantly
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bronchoalveolar lavage fluid (BALF), before and after the initiation of
each challenge: a) interleukin (IL)-2; b) IL-5; c) IL-13; d) TGF-β; e) IL-6; f) IL-
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Additional file 5: Correlations (95% confidence interval) between
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before and after the initiation of each challenge. IL, interleukin; (95% CI);
ns, non-significant and/or absolute value of R < 0.5. (DOCX 21 kb)
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